Partillion wins $2.1 million NIH award to expand Cell-Cell-seq workflows

Verifying
  • Partillion Bioscience received an NIH award to expand its Cell-Cell-seq workflows.
  • $2.1 million will fund a two-year project through NIH's Direct-to-Phase II mechanism.
  • Partillion's 10th SBIR grant raises non-dilutive federal funding above $8 million.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.